Price Controls of Drugs and the Potential Impact on the Biotech and Pharma Industry – GEN’s Editor-in-Chief John Sterling talks with Dr. Elizabeth Whelan , President of the American Council on Science and Health about this controversial topic.

Previous articleGalapagos Adds Discovery Tools to its Services Business for $16.63M
Next articleBroad Institute Obtains $200M for Genomics Research